Relmada Therapeutics, Inc. (RLMD)
Nasdaq: RLMD · Pharmaceutical Preparations · Coral Gables, FL · filing with the SEC since 2012
Who runs Relmada Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Traversa Sergio
Chief Executive Officer. First filing Jan 2015, latest Sep 11, 2026, 16 filings in all.
Officers reporting now
4
of 7 people with a filing in the last fifteen months
Directors reporting now
3
12 people on the record since 2015
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Traversa Sergio | Chief Executive Officer | Jan 2015 | Sep 11, 2026 | none |
| Shenouda Maged | Chief Financial Officer | Nov 2015 | Sep 11, 2026 | none |
| Kelly Paul Edward | COO | Nov 2015 | Dec 16, 2025 | none |
| Ence Chuck | CA and CO | Jul 2019 | Dec 16, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Casamento Charles J | director | Jul 2015 | Dec 16, 2025 | none |
| Fedeli Fabiana | director | Jan 2023 | Dec 16, 2025 | none |
| Glasspool John | director | Jan 2020 | Dec 16, 2025 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.